Central inhibition of granulocyte-macrophage colony-stimulating factor is analgesic in experimental neuropathic pain

With less than 50% of patients responding to the current standard of care and poor efficacy and selectivity of current treatments, neuropathic pain continues to be an area of considerable unmet medical need. Biological therapeutics such as monoclonal antibodies (mAbs) provide better intrinsic select...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pain
Asıl Yazarlar: Nicol, Louise S.C., Thornton, Peter, Hatcher, Jon P., Glover, Colin P., Webster, Carl I., Burrell, Matthew, Hammett, Kessia, Jones, Clare A., Sleeman, Matthew A., Billinton, Andrew, Chessell, Iain
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer 2018
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828377/
https://ncbi.nlm.nih.gov/pubmed/29351125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/j.pain.0000000000001130
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller